Halozyme appoints Jim Daly to board of directors
Bitget2026/09/30 20:08- Halozyme appointed James “Jim” Daly to its board of directors.
- Daly was Incyte’s executive vice president and chief commercial officer from 2012 to 2015.
- He previously spent a decade at Amgen, most recently as senior vice president for North America commercial operations, global marketing, commercial development.
- Earlier, Daly spent more than 16 years at Glaxo Wellcome/GlaxoSmithKline, including senior vice president and general manager of the U.S. respiratory business.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.
The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.
Turtle Creek Asset Management Reports Sale of $347,850 in Jeld-Wen Common Shares
GLOBALFOUNDRIES Director Ganesh Moorthy Reports $93,687.50 Share Acquisition
Crypto prices
More
